Newswire (Published: Tuesday, May 22, 2018, Received: Friday, May 18, 2018, 3:41:21 AM CDT)

Word Count: 496

New Prostate Cancer Findings from University of Miami Reported (Imaging for the selection and monitoring of men on active surveillance for prostate cancer)

By a News Reporter-Staff News Editor at Cancer Weekly -- New research on Oncology - Prostate Cancer is the subject of a report. According to news reporting out of Miami, Florida, by NewsRx editors, research stated, "Traditional prostate imaging is fairly limited, and only a few imaging modalities have been used for this purpose. Until today, grey scale ultrasound was the most widely used method for the characterization of the prostatic gland, however its limitations for prostate cancer (PCa) detection are well known and hence ultrasound is primarily used to localize the prostate and facilitate template prostate biopsies."

Our news journalists obtained a quote from the research from the University of Miami, "In the past decade, multiparametric magnetic resonance imaging (mpMRI) of the prostate has emerged as a promising tool for the detection of PCa. Evidence has shown the value of mpMRI in the active surveillance (AS) population, given its ability to detect more aggressive disease, with data building up and supporting its use for the selection of patients suitable for surveillance. Additionally, mpMRI targeted biopsies have shown an improved detection rate of aggressive PCa when compared to regular transrectal ultrasound (TRUS) guided biopsies. Current data supports the use of mpMRI in patients considered for AS for reclassification purposes; with a negative mpMRI indicating a decreased risk of reclassification. However, a percentage of patients with negative imaging or low suspicion lesions can experience reclassification, highlighting the importance of repeat confirmatory biopsy regardless of mpMRI findings."

According to the news editors, the research concluded: "At present, no robust data is available to recommend the substitution of regular biopsies with mpMRI in the follow-up of patients on AS and efforts are being made to determine the role of integrating genomic markers with imaging with the objective of minimizing the need of biopsies during the follow up period."

For more information on this research see: Imaging for the selection and monitoring of men on active surveillance for prostate cancer. Translational Andrology and Urology, 2018;7(2):228-235 (see also Oncology - Prostate Cancer).

Our news journalists report that additional information may be obtained by contacting M.C. Velasquez, Dept. of Urology, University of Miami, Miami, FL, United States. Additional authors for this research include N.S. Prakash, V. Venkatramani, B. Nahar and S. Punnen.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.21037/tau.2017.08.13. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Keywords for this news article include: Miami, Florida, Oncology, Epidemiology, United States, Prostate Cancer, Health and Medicine, Prostatic Neoplasms, North and Central America.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC

Companies

University of Miami

Places

Central America
North America
United States
Americas
Florida
Miami

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Medical Specialties and Practices
            Urology